Lipigon Pharmaceuticals AB (OSTO:LPGO) Total Assets : kr33.60 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB Total Assets?

Lipigon Pharmaceuticals AB's Total Assets for the quarter that ended in Dec. 2023 was kr33.60 Mil.

During the past 12 months, Lipigon Pharmaceuticals AB's average Total Assets Growth Rate was 42.10% per year. During the past 3 years, the average Total Assets Growth Rate was -14.60% per year. During the past 5 years, the average Total Assets Growth Rate was 48.00% per year.

During the past 6 years, Lipigon Pharmaceuticals AB's highest 3-Year average Total Assets Growth Rate was 101.20%. The lowest was -14.60%. And the median was 18.00%.

Total Assets is connected with ROA %. Lipigon Pharmaceuticals AB's annualized ROA % for the quarter that ended in Dec. 2023 was -99.97%. Total Assets is also linked to Revenue through Asset Turnover. Lipigon Pharmaceuticals AB's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Lipigon Pharmaceuticals AB Total Assets Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB Total Assets Chart

Lipigon Pharmaceuticals AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

3.21

15.24

29.43

10.82

33.60

Lipigon Pharmaceuticals AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial												16.83	10.82	35.12	26.86	33.60

Lipigon Pharmaceuticals AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Lipigon Pharmaceuticals AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	28.444	+	5.158
	=	33.60

Lipigon Pharmaceuticals AB's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	28.444	+	5.158
	=	33.60

Lipigon Pharmaceuticals AB (OSTO:LPGO) Total Assets Explanation

Total Assets is connected with ROA %.

Lipigon Pharmaceuticals AB's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-30.224	/	( (26.863	+	33.602)	/ 2 )
	=	-30.224	/	30.2325
	=	-99.97 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Lipigon Pharmaceuticals AB's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (26.863	+	33.602)	/ 2 )
=	0	/	30.2325
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Lipigon Pharmaceuticals AB Total Assets Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

9RP:Germany

Address

Tvistevagen 48 C, Umea, SWE, 90736

Website

https://www.lipigon.se

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines